{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:37:06Z","timestamp":1793846226394,"version":"4.6.1"},"reference-count":489,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.anai.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:29:06Z","timestamp":1702859346000},"page":"124-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":361,"title":["Anaphylaxis: A 2023 practice parameter update"],"prefix":"10.1016","volume":"132","author":[{"given":"David B.K.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Waserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronna L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Ledford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Stukus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa G.","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronna L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Ledford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Waserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Ledford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Stukus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaip.2022.09.019","article-title":"Anaphylaxis: advances in the past 10 years","volume":"11","author":"Weiler","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2013a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0004","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis: a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0006","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jaci.2021.07.035","article-title":"Anaphylaxis knowledge gaps and future research priorities: a consensus report","volume":"149","author":"Dribin","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0007","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jemermed.2013.01.018","article-title":"Customizing anaphylaxis guidelines for emergency medicine","volume":"45","author":"Nowak","year":"2013","journal-title":"J Emerg Med"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0008","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaci.2021.02.034","article-title":"Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: A Work Group Report of the AAAAI Committee on the Underserved","volume":"147","author":"Davis","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0009","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","article-title":"A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force","volume":"56","author":"Johansson","year":"2001","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/adc.2004.069914","article-title":"Paediatric emergency department anaphylaxis: different patterns from adults","volume":"91","author":"Braganza","year":"2006","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/j.1326-5377.2006.tb00563.x","article-title":"Anaphylaxis: diagnosis and management","volume":"185","author":"Brown","year":"2006","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"31","key":"10.1016\/j.anai.2023.09.015_bib0013","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.06.022","article-title":"The diagnosis and management of anaphylaxis practice parameter: 2010 update","volume":"126","author":"Lieberman","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World Allergy Organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0016","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/qjmed\/hct179","article-title":"Anaphylaxis: incidence, presentation, causes and outcome in patients in a tertiary-care hospital in Karachi, Pakistan","volume":"106","author":"Khan","year":"2013","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0017","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0018","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/all.12765","article-title":"Time for a new grading system for allergic reactions?","volume":"71","author":"Niggemann","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.09.015_bib0020","unstructured":"World Health Organization. ICD-11 for mortality and morbidity statistics. Available at: https:\/\/icd.who.int\/browse11\/l-m\/en#\/http:\/\/id.who.int\/icd\/entity\/1868068711. Accessed July 14, 2021."},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100066","article-title":"Time to revisit the definition and clinical criteria for anaphylaxis?","volume":"12","author":"Turner","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2023.09.015_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-020-00317-y","article-title":"EAACI task force Clinical epidemiology of anaphylaxis: experts\u2019 perspective on the use of adrenaline autoinjectors in Europe","volume":"10","author":"Kraft","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2023.09.015_bib0024","unstructured":"Australia Society of Clinical Immunology and Allergy. Acute management of anaphylaxis. Available at: https:\/\/www.allergy.org.au\/hp\/\/papers\/acute-management-of-anaphylaxis-guidelines. Accessed July 13, 2021."},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0026","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1081-1206(10)60714-4","article-title":"Fatal anaphylaxis: postmortem findings and associated comorbid diseases","volume":"98","author":"Greenberger","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"15","key":"10.1016\/j.anai.2023.09.015_bib0035","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","article-title":"Anaphylaxis: revision of the Brighton collaboration case definition","volume":"41","author":"Gold","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0028","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaip.2016.06.003","article-title":"Prospective validation of the NIAID\/FAAN criteria for emergency department diagnosis of anaphylaxis","volume":"4","author":"Loprinzi Brauer","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.24953\/turkjped.2021.03.004","article-title":"Healthcare workers; knowledge level regarding anaphylaxis and usage of epinephrine auto-injectors","volume":"63","author":"Arga","year":"2021","journal-title":"Turk J Pediatr"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/EDE.0000000000001330","article-title":"Identification and validation of anaphylaxis using electronic health data in a population-based setting","volume":"32","author":"Bann","year":"2021","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/11318970-000000000-00000","article-title":"Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK","volume":"33","author":"Erlewyn-Lajeunesse","year":"2010","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0032","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.jaip.2021.04.025","article-title":"Ascertainment bias in anaphylaxis safety data of COVID-19 vaccines","volume":"9","author":"Hourihane","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0033","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.anai.2022.01.040","article-title":"We should not abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis","volume":"129","author":"Blumenthal","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0034","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/all.14580","article-title":"Diagnosing, managing and preventing anaphylaxis: systematic review","volume":"76","author":"de Silva","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0036","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaip.2021.11.031","article-title":"Reproducibility of symptom sequences across episodes of recurrent anaphylaxis","volume":"10","author":"Slapnicar","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0037","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2020.08.015","article-title":"Persistent, refractory, and biphasic anaphylaxis: a multidisciplinary Delphi study","volume":"146","author":"Dribin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0038","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1542\/peds.106.4.762","article-title":"Biphasic anaphylactic reactions in pediatrics","volume":"106","author":"Lee","year":"2000","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0039","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1365-2222.2009.03276.x","article-title":"Clinical predictors for biphasic reactions in children presenting with anaphylaxis","volume":"39","author":"Mehr","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0040","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00330-017-5052-0","article-title":"Biphasic and protracted anaphylaxis to iodinated contrast media","volume":"28","author":"Kim","year":"2018","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0041","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/all.12404","article-title":"Biphasic anaphylactic reactions: occurrence and mortality","volume":"69","author":"Rohacek","year":"2014","journal-title":"Allergy"},{"issue":"1 Pt 1","key":"10.1016\/j.anai.2023.09.015_bib0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0091-6749(86)90117-X","article-title":"Biphasic and protracted anaphylaxis","volume":"78","author":"Stark","year":"1986","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0043","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000496092","article-title":"Duration of observation for detecting a biphasic reaction in anaphylaxis: a meta-analysis","volume":"179","author":"Kim","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0044","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1081-1206(10)60861-7","article-title":"Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients","volume":"98","author":"Ellis","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2013.10.017","article-title":"Incidence of clinically important biphasic reactions in emergency department patients with allergic reactions or anaphylaxis","volume":"63","author":"Grunau","year":"2014","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0046","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaip.2017.05.022","article-title":"Do corticosteroids prevent biphasic anaphylaxis?","volume":"5","author":"Alqurashi","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.anai.2015.05.013","article-title":"Epidemiology and clinical predictors of biphasic reactions in children with anaphylaxis","volume":"115","author":"Alqurashi","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0048","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2500\/aap.2013.34.3654","article-title":"Characteristics of anaphylaxis in children referred to a tertiary care center","volume":"34","author":"Vezir","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0049","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.anai.2015.12.028","article-title":"Refractory anaphylaxis: further considerations for emergency care providers","volume":"116","author":"Alqurashi","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.iac.2007.03.003","article-title":"The pathophysiology of shock in anaphylaxis","volume":"27","author":"Brown","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2023.09.015_bib0051","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3389\/fimmu.2019.02482","article-title":"Refractory anaphylaxis: data from the European Anaphylaxis Registry","volume":"10","author":"Francuzik","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0052","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajem.2022.08.035","article-title":"Cardiac arrest caused by anaphylaxis refractory to prompt management","volume":"61","author":"Park","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0053","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mcna.2019.08.007","article-title":"Anaphylaxis for internists: definition, evaluation, and management, with a focus on commonly encountered problems","volume":"104","author":"Chu","year":"2020","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0054","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0055","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0056","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0057","doi-asserted-by":"crossref","first-page":"91","DOI":"10.20344\/amp.10820","article-title":"Anaphylactic reactions in the emergency department of a Portuguese tertiary hospital: clinical characterization and disease notification","volume":"32","author":"Fr\u00f3is","year":"2019","journal-title":"Acta Med Port"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0058","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaci.2014.05.018","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals","volume":"134","author":"Clark","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0059","first-page":"45","article-title":"Anaphylaxis in an emergency department: epidemiology, clinical features and management","volume":"95","author":"Ghazali","year":"2017","journal-title":"Tunis Med"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0060","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/all.13408","article-title":"The urgent need for a harmonized severity scoring system for acute allergic reactions","volume":"73","author":"Muraro","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0061","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/archdischild-2018-314867","article-title":"Myths, facts and controversies in the diagnosis and management of anaphylaxis","volume":"104","author":"Anagnostou","year":"2019","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0062","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40413-015-0081-0","article-title":"Risk multipliers for severe food anaphylaxis","volume":"8","author":"Smith","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0063","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/all.13405","article-title":"How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods?: report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop","volume":"73","author":"Dubois","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0064","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2021.01.003","article-title":"Severity grading system for acute allergic reactions: a multidisciplinary Delphi study","volume":"148","author":"Dribin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12924","article-title":"Can we identify patients at risk of life-threatening allergic reactions to food?","volume":"71","author":"Turner","year":"2016","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0066","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0067","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report","volume":"130","author":"Sampson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0068","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaip.2016.11.009","article-title":"World Allergy Organization systemic allergic reaction grading system: is a modification needed?","volume":"5","author":"Cox","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8009","key":"10.1016\/j.anai.2023.09.015_bib0069","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0070","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.bja.2019.04.044","article-title":"Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0071","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/jclinpath-2013-202005","volume":"67","author":"Srivastava","year":"2014","journal-title":"J Clin Pathol"},{"issue":"6 Pt 3","key":"10.1016\/j.anai.2023.09.015_bib0072","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1542\/peds.111.S3.1601","article-title":"Anaphylaxis and emergency treatment","volume":"111","author":"Sampson","year":"2003","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0073","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.2007.01421.x","article-title":"The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology","volume":"62","author":"Muraro","year":"2007","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0074","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0075","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0076","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jaci.2021.12.789","article-title":"Updating the CoFAR grading scale for systemic allergic reactions in food allergy","volume":"149","author":"Chinthrajah","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0077","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/all.15165","article-title":"Development and validation of the food allergy severity score","volume":"77","author":"Fernandez-Rivas","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0078","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.anai.2021.04.015","article-title":"A severity grading system of food-induced acute allergic reactions to avoid the delay of epinephrine administration","volume":"127","author":"Blazowski","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0079","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.jaip.2021.06.056","article-title":"Improving severity scoring of food-induced allergic reactions: a global \u201cbest-worst scaling\u201d exercise","volume":"9","author":"Stafford","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0080","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/all.13226","article-title":"Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective","volume":"72","author":"Baretto","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0081","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jaci.2015.09.001","article-title":"Tryptase levels in children presenting with anaphylaxis: temporal trends and associated factors","volume":"137","author":"De Schryver","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0082","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0083","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0084","unstructured":"National Institute of Allergy and Infectious Diseases. Total Rise in Peripheral Tryptase after Systemic Event (TRIPTASAE) Calculator. Available at: https:\/\/triptase-calculator.niaid.nih.gov. Accessed November 5, 2022."},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0086","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0087","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jaip.2022.05.003","article-title":"Incorporating tryptase genotyping into the workup and diagnosis of mast cell diseases and reactions","volume":"10","author":"Lyons","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0088","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0089","unstructured":"National Institute of Allergy and Infectious Diseases. Basal Serum Tryptase Clinical Cut-Off Assigned by Locus Copy Number of UTR-Linked Element and Associated TPSAB1-Encoded Replication (BST Calculator). Available at: https:\/\/bst-calculater.niaid.nih.gov. Accessed November 5, 2022."},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0090","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0091","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jaci.2022.04.025","article-title":"Castells M. Differential mast cell mediators in systemic mastocytosis and hereditary alpha-tryptasemia","volume":"150","author":"Giannetti","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0092","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0093","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0094","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2020.11.017","article-title":"Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology","volume":"147","author":"Giannetti","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0096","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0097","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0098","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.jaip.2021.04.062","article-title":"Diagnosis of primary mast cell disorders in anaphylaxis: value of KIT D816V in peripheral blood","volume":"9","author":"De Puysseleyr","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0099","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The presence of mast cell clonality in patients with unexplained anaphylaxis","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0101","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jaip.2019.11.003","article-title":"Diagnostic challenges in anaphylaxis","volume":"8","author":"Lieberman","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0102","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/all.13366","article-title":"Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis","volume":"73","author":"Carter","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0103","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.anai.2018.07.017","article-title":"The changing face of anaphylaxis in adults and adolescents","volume":"121","author":"Pattanaik","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0104","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.jaip.2020.12.021","article-title":"Prevalence of alpha-gal sensitization among Kentucky timber harvesters and forestry and wildlife practitioners","volume":"9","author":"Bellamy","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0105","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/all.13156","article-title":"Prevalence of type I sensitization to alpha-gal in forest service employees and hunters","volume":"72","author":"Fischer","year":"2017","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0106","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/pai.12969","article-title":"Predictive values of alpha-gal IgE levels and alpha-gal IgE: total IgE ratio and oral food challenge-proven meat allergy in a population with a high prevalence of reported red meat allergy","volume":"29","author":"Mabelane","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"19","key":"10.1016\/j.anai.2023.09.015_bib0107","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.3390\/jcm11195494","article-title":"The timely administration of epinephrine and related factors in children with anaphylaxis","volume":"11","author":"Cha","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0108","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.jaip.2022.09.015","article-title":"Impact of reaction setting on the management, severity, and outcome of pediatric food-induced anaphylaxis: a cross-sectional study","volume":"10","author":"Prosty","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"18","key":"10.1016\/j.anai.2023.09.015_bib0109","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.3390\/jcm11185285","article-title":"Pediatric anaphylaxis: a 20-year retrospective analysis","volume":"11","author":"De Filippo","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0009922820946012","article-title":"What is anaphylaxis? Pediatric residents\u2019 perception and treatment of anaphylactic reactions","volume":"60","author":"Ferdman","year":"2021","journal-title":"Clin Pediatr (Phila)"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100599","article-title":"Knowledge of healthcare providers in the management of anaphylaxis","volume":"14","author":"Gonz\u00e1lez-D\u00edaz","year":"2021","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/PEC.0000000000001617","article-title":"Missed diagnosis of anaphylaxis in patients with pediatric urticaria in the emergency department","volume":"37","author":"Jung","year":"2021","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0113","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/all.14683","article-title":"Peanut-induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry","volume":"76","author":"Maris","year":"2021","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0114","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jaip.2021.01.038","article-title":"Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis","volume":"9","author":"Miles","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: Anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0116","first-page":"e29336","article-title":"Real world management of anaphylaxis versus the National Institute for Health and Clinical Excellence (NICE) guidelines","volume":"14","author":"Nasr","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0117","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3390\/jpm12091477","article-title":"Diagnosis, management and prescription practices of adrenaline in children with food-induced anaphylaxis: audit in a specialized pediatric allergy department","volume":"12","author":"Vamvakaris","year":"2022","journal-title":"J Pers Med"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0118","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1016\/j.jaip.2022.10.016","article-title":"The influence of systems and settings on the management of anaphylaxis","volume":"10","author":"Tsoulis","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0119","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/all.14580","article-title":"Diagnosing, managing and preventing anaphylaxis: systematic review","volume":"76","author":"de Silva","year":"2021","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0120","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jaip.2018.02.026","article-title":"Epinephrine in severe allergic reactions: the European Anaphylaxis Register","volume":"6","author":"Grabenhenrich","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000059406","article-title":"Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock","volume":"128","author":"Bautista","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0122","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic reactions to food in children and adolescents","volume":"327","author":"Sampson","year":"1992","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0123","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jaip.2018.04.036","article-title":"The health and economic outcomes of peanut allergy management practices","volume":"6","author":"Shaker","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0124","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.anai.2014.12.022","article-title":"Treatment of allergic reactions and quality of life among caregivers of food-allergic children","volume":"114","author":"Ward","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0125","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaip.2016.05.005","article-title":"The emperor has no ymptoms: the risks of a blanket approach to using epinephrine autoinjectors for all allergic reactions","volume":"4","author":"Turner","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0126","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/archdischild-2020-319906","article-title":"Self-administration of adrenaline for anaphylaxis during in-hospital food challenges improves health-related quality of life","volume":"106","author":"Burrell","year":"2021","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0127","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2020.06.033","article-title":"Cardiovascular changes during peanut-induced allergic reactions in human subjects","volume":"147","author":"Ruiz-Garcia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2018.06.035","article-title":"An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis","volume":"122","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0129","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaip.2020.04.022","article-title":"Acute at home management of anaphylaxis during the COVID-19 pandemic","volume":"8","author":"Casale","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jaip.2020.03.012","article-title":"COVID-19: pandemic contingency planning for the allergy and immunology clinic","volume":"8","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.anai.2018.08.019","article-title":"Shared decision making for the allergist","volume":"122","author":"Blaiss","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0132","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jaip.2022.04.040","article-title":"Acute at-home management of anaphylaxis: 911: what is the emergency?","volume":"10","author":"Casale","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0133","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/pai.12908","article-title":"National trends in emergency department visits and hospitalizations for food-induced anaphylaxis in US children","volume":"29","author":"Motosue","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0134","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.anai.2015.05.006","article-title":"Pediatric emergency department visits and hospitalizations due to food-induced anaphylaxis in Illinois","volume":"115","author":"Dyer","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0135","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","article-title":"Anaphylaxis in children and adolescents: the European Anaphylaxis Registry","volume":"137","author":"Grabenhenrich","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0136","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaip.2020.09.018","article-title":"Food-induced anaphylaxis in infants: can new evidence assist with implementation of food allergy prevention and treatment?","volume":"9","author":"Tsuang","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100605","article-title":"Age-related differences in characteristics of anaphylaxis in Chinese children from infancy to adolescence","volume":"14","author":"Jiang","year":"2021","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0138","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaip.2018.10.052","article-title":"Guiding principles for the recognition, diagnosis, and management of infants with anaphylaxis: an expert panel consensus","volume":"7","author":"Greenhawt","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0139","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jaip.2021.01.010","article-title":"Trends in US Emergency Department visits for anaphylaxis among infants and toddlers: 2006-2015","volume":"9","author":"Robinson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2023.09.015_bib0140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2020.09.003","article-title":"Trends in US hospitalizations for anaphylaxis among infants and toddlers: 2006 to 2015","volume":"126","author":"Robinson","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0141","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.anai.2023.09.015_bib0142","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1514210","article-title":"Randomized trial of introduction of allergenic foods in breast-fed infants","volume":"374","author":"Perkin","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.05.002","article-title":"Early regular egg exposure in infants with eczema: a randomized controlled trial","volume":"132","author":"Palmer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0144","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jaci.2016.06.052","article-title":"Randomized controlled trial of early regular egg intake to prevent egg allergy","volume":"139","author":"Palmer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"10066","key":"10.1016\/j.anai.2023.09.015_bib0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0140-6736(16)31418-0","article-title":"Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial","volume":"389","author":"Natsume","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0146","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jaci.2016.06.045","article-title":"Randomized placebo-controlled trial of hen's egg consumption for primary prevention in infants","volume":"139","author":"Bellach","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0147","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jaci.2016.08.035","article-title":"A randomized trial of egg introduction from 4 months of age in infants at risk for egg allergy","volume":"139","author":"Wei-Liang Tan","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0148","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2019.07.032","article-title":"Earlier ingestion of peanut after changes to infant feeding guidelines: the EarlyNuts study","volume":"144","author":"Soriano","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0149","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100449","article-title":"A multicenter anaphylaxis registry in Korea: clinical characteristics and acute treatment details from infants to older adults","volume":"13","author":"Jeong","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0150","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpeds.2010.10.017","article-title":"Age-related differences in the clinical presentation of food-induced anaphylaxis","volume":"158","author":"Rudders","year":"2011","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0151","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2018.05.025","article-title":"Food-induced anaphylaxis in infants and children","volume":"121","author":"Samady","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0152","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/all.13717","article-title":"Food-related anaphylaxis fatalities: analysis of the Allergy Vigilance Network database","volume":"74","author":"Pouessel","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0153","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaip.2020.11.005","article-title":"Caregiver-reported presentation of severe Food-induced allergic reactions in infants and toddlers","volume":"9","author":"Pistiner","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0154","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaci.2014.09.014","article-title":"Anaphylaxis: unique aspects of clinical diagnosis and management in infants (birth to age 2 years)","volume":"135","author":"Simons","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"B","key":"10.1016\/j.anai.2023.09.015_bib0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbr.2015.10.036","article-title":"Brain functional connectivity patterns for emotional state classification in Parkinson's disease patients without dementia","volume":"298","author":"Yuvaraj","year":"2016","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0156","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.anai.2017.03.017","article-title":"Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers","volume":"118","author":"Kim","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0157","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.anai.2018.02.028","article-title":"Epinephrine auto-injector needle lengths: can both subcutaneous and periosteal\/intraosseous injection be avoided?","volume":"120","author":"Dreborg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0158","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13223-018-0257-6","article-title":"Unintentional injection to the bone with a pediatric epinephrine auto-injector","volume":"14","author":"Ibrahim","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0159","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.1486","article-title":"Relevance of casual contact with peanut butter in children with peanut allergy","volume":"112","author":"Simonte","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1034\/j.1398-9995.2002.03366.x","article-title":"Bronchial challenges with aerosolized food in asthmatic, food-allergic children","volume":"57","author":"Roberts","year":"2002","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0161","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2004.02.035","article-title":"Distribution of peanut allergen in the environment","volume":"113","author":"Perry","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0162","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2500\/aap.2013.34.3622","article-title":"Airborne concentrations of peanut protein","volume":"34","author":"Johnson","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0163","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaci.2013.02.035","article-title":"Distribution of peanut protein in the home environment","volume":"132","author":"Brough","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1440-1754.2000.00444.x","article-title":"Parent reported allergy and anaphylaxis in 4173 South Australian children","volume":"36","author":"Boros","year":"2000","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0165","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1398-9995.2008.01719.x","article-title":"Paediatric anaphylaxis: a 5 year retrospective review","volume":"63","author":"de Silva","year":"2008","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0166","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00431-007-0661-2","article-title":"Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach","volume":"167","author":"De Swert","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0167","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1542\/peds.101.4.e8","article-title":"Anaphylaxis in children: clinical and allergologic features","volume":"101","author":"Novembre","year":"1998","journal-title":"Pediatrics"},{"issue":"suppl 99","key":"10.1016\/j.anai.2023.09.015_bib0168","first-page":"273","article-title":"Anaphylaxis in children: demographic and clinical features and triggers","volume":"69","author":"Katsunuma","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0169","first-page":"197","article-title":"One-year survey of paediatric anaphylaxis in an allergy department","volume":"47","author":"Gaspar","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0170","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1365-2222.2011.03859.x","article-title":"Anaphylaxis in Turkish children: a multi-centre, retrospective, case study","volume":"41","author":"Orhan","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0171","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/10903127.2013.825352","article-title":"Pediatric anaphylaxis management in the prehospital setting","volume":"18","author":"Tiyyagura","year":"2014","journal-title":"Prehosp Emerg Care"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0172","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1398-9995.2005.00909.x","article-title":"Anaphylactic reactions in children: a questionnaire-based survey in Germany","volume":"60","author":"Mehl","year":"2005","journal-title":"Allergy"},{"issue":"suppl 94","key":"10.1016\/j.anai.2023.09.015_bib0173","first-page":"407","article-title":"Immediate food-allergic children visited to our hospital emergency room","volume":"66","author":"Masumoto","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.09.015_bib0174","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1186\/s13601-015-0055-x","article-title":"Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy","volume":"5","author":"Cherkaoui","year":"2015","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-3038.2011.01235.x","article-title":"Inadvertent exposures in children with peanut allergy","volume":"23","author":"Nguyen-Luu","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0176","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2006.04.024","article-title":"Accidental ingestions in children with peanut allergy","volume":"118","author":"Yu","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0177","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2008.05.015","article-title":"Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center","volume":"122","author":"Clark","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0178","doi-asserted-by":"crossref","first-page":"159.e7","DOI":"10.1186\/s12887-015-0477-6","article-title":"Acute and preventive management of anaphylaxis in German primary school and kindergarten children","volume":"15","author":"Kilger","year":"2015","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0179","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2222.2005.02162.x","article-title":"Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France","volume":"35","author":"Rance","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0180","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10903127.2017.1402110","article-title":"Pediatric anaphylaxis in the prehospital setting: incidence, characteristics, and management","volume":"22","author":"Andrew","year":"2018","journal-title":"Prehosp Emerg Care"},{"issue":"suppl 19","key":"10.1016\/j.anai.2023.09.015_bib0181","article-title":"Anaphylaxis: closer to home?","volume":"119","author":"Anvari","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl 103","key":"10.1016\/j.anai.2023.09.015_bib0182","first-page":"767","article-title":"Anaphylaxis induced by tree nuts in preschool age children","volume":"72","author":"Azevedo","year":"2017","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0183","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10903127.2015.1086843","article-title":"Prehospital administration of epinephrine in pediatric anaphylaxis","volume":"20","author":"Carrillo","year":"2016","journal-title":"Prehosp Emerg Care"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0184","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/pai.12770","article-title":"Food-induced anaphylaxis to a known food allergen in children often occurs despite adult supervision","volume":"28","author":"De Schryver","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0185","first-page":"12","article-title":"The features of anaphylaxis cases followed in the pediatric allergy clinic","volume":"15","author":"Dogru","year":"2017","journal-title":"Guncel Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0186","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00431-018-3246-3","article-title":"Use of epinephrine in emergency department depends on anaphylaxis severity in children","volume":"178","author":"Dubus","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0187","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.aller.2019.07.009","article-title":"Physicians prescribe adrenaline autoinjectors, do parents use them when needed?","volume":"48","author":"Esenboga","year":"2019","journal-title":"Allergol Immunopathol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0188","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.alit.2017.07.002","article-title":"Surveillance of the use of adrenaline auto-injectors in Japanese children","volume":"67","author":"Ito","year":"2018","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0189","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4168\/aair.2017.9.5.423","article-title":"Age-based causes and clinical characteristics of immediate-type food allergy in Korean children","volume":"9","author":"Jeong","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5415\/apallergy.2017.7.1.37","article-title":"Administration of the adrenaline auto-injector at the nursery\/kindergarten\/school in Western Japan","volume":"7","author":"Korematsu","year":"2017","journal-title":"Asia Pac Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0191","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jaci.2017.09.012","article-title":"Self-reported adverse food reactions and anaphylaxis in the SchoolNuts study: a population-based study of adolescents","volume":"141","author":"McWilliam","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0192","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jpc.13173","article-title":"The diagnosis and management of children presenting with anaphylaxis to a metropolitan emergency department: a 2-year retrospective case series","volume":"52","author":"Nogic","year":"2016","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0193","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/cea.13287","article-title":"Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies","volume":"48","author":"Pouessel","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0194","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/pai.13015","article-title":"Anaphylaxis admissions in pediatric intensive care units: follow-up and risk of recurrence","volume":"30","author":"Pouessel","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cea.13519","article-title":"Food-induced anaphylaxis in infancy compared to preschool age: a retrospective analysis","volume":"50","author":"Pouessel","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0196","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jaip.2017.04.036","article-title":"Inpatient interventions are infrequent during pediatric hospitalizations for food-induced anaphylaxis","volume":"5","author":"Rudders","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0197","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jpc.13483","article-title":"Inaccurate diagnosis of paediatric anaphylaxis in three Australian Emergency Departments","volume":"53","author":"Thomson","year":"2017","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0198","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.anai.2017.02.002","article-title":"An analysis of anaphylaxis cases at a single pediatric emergency department during a 1-year period","volume":"118","author":"Wright","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0199","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.anai.2017.06.001","article-title":"Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department","volume":"119","author":"Robinson","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0200","first-page":"212","article-title":"The etiology and clinical features of anaphylaxis in a developing country: a nationwide survey in Turkey","volume":"35","author":"Civelek","year":"2017","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0201","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2222.2005.02257.x","article-title":"Allergic reactions in the community: A questionnaire survey of members of the anaphylaxis campaign","volume":"35","author":"Uguz","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0202","doi-asserted-by":"crossref","DOI":"10.1177\/2054270415593443","article-title":"Anaphylaxis in the community: a questionnaire survey of members of the UK Anaphylaxis Campaign","volume":"6","author":"Sheikh","year":"2015","journal-title":"JRSM Open"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2008.12.1125","article-title":"Accidental allergic reactions in children allergic to cow's milk proteins","volume":"123","author":"Boyano-Martinez","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"10.1016\/j.anai.2023.09.015_bib0204","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/mai.2000.106041","article-title":"First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen)","volume":"106","author":"Gold","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0205","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0206","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2007.01.021","article-title":"Further fatal allergic reactions to food in the United Kingdom, 1999-2006","volume":"119","author":"Pumphrey","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0207","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/all.12475","article-title":"First European data from the network of severe allergic reactions (NORA)","volume":"69","author":"Worm","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0208","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mai.2001.115755","article-title":"A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants","volume":"108","author":"Sicherer","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0209","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1034\/j.1398-9995.2001.056006540.x","article-title":"An Internet-based survey of anaphylactic reactions to foods","volume":"56","author":"Eigenmann","year":"2001","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.anai.2018.06.015","article-title":"Risk factors for multiple epinephrine doses in food-triggered anaphylaxis in children","volume":"121","author":"Tsuang","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0212","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jaci.2021.01.034","article-title":"Prevention and management of allergic reactions to food in child care centers and schools: practice guidelines","volume":"147","author":"Waserman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9250","key":"10.1016\/j.anai.2023.09.015_bib0213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(00)03543-1","article-title":"Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan","volume":"357","author":"Ewan","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0214","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2222.2005.02266.x","article-title":"Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice","volume":"35","author":"Ewan","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0215","doi-asserted-by":"crossref","first-page":"AB211","DOI":"10.1016\/j.jaci.2014.12.1624","article-title":"School staff food allergy (FA) education increases epinephrine coverage and recognition of allergic reactions","volume":"135","author":"Kourosh","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0216","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1034\/j.1398-9995.2001.00047.x","article-title":"Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit","volume":"56","author":"Moneret-Vautrin","year":"2001","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0217","doi-asserted-by":"crossref","first-page":"AB288","DOI":"10.1016\/j.jaci.2013.12.1018","article-title":"Longitudianal effect of food allergy education on epinephrine availability in public schools","volume":"133","author":"Patel","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0218","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaip.2018.05.015","article-title":"Benefits of school nurse training sessions for food allergy and anaphylaxis management","volume":"7","author":"Tsuang","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0219","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaip.2017.08.013","article-title":"Quality of life for parents of children with food allergy in peanut-restricted versus peanut-free schools in the United States and Canada","volume":"6","author":"Patel","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0220","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2017.01.040","article-title":"Impact of school peanut-free policies on epinephrine administration","volume":"140","author":"Bartnikas","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0221","unstructured":"Food Allergy & Anaphylaxis Connection Team. Government Relations: school access to emergency epinephrine federal legislation. Available at: https:\/\/www.foodallergyawareness.org\/government-relations\/school-access-to-emergency-epinephrine-act\/. Accessed September 15, 2022."},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203496","article-title":"A systematic review and meta-regression of the knowledge, practices, and training of restaurant and food service personnel toward food allergies and celiac disease","volume":"13","author":"Young","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0223","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4315\/0362-028X.JFP-16-085","article-title":"Food allergy knowledge and attitudes of restaurant managers and staff: an EHS-net study","volume":"79","author":"Radke","year":"2016","journal-title":"J Food Prot"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214625","article-title":"Food allergy knowledge, attitudes and their determinants among restaurant staff: a cross-sectional study","volume":"14","author":"Loerbroks","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.anai.2023.09.015_bib0225","unstructured":"US Food and Drug Administration. Food allergen labeling and consumer protection act of 2004 (FALCPA). Available at: https:\/\/www.fda.gov\/food\/food-allergensgluten-free-guidance-documents-regulatory-information\/food-allergen-labeling-and-consumer-protection-act-2004-falcpa. Accessed September 15, 2022."},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0226","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jaip.2020.12.018","article-title":"Characteristics of food allergic reactions in United States restaurants","volume":"9","author":"Oriel","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0227","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaip.2021.09.041","article-title":"Restaurant takeout practices of food-allergic individuals and associated allergic reactions in the COVID-19 era","volume":"10","author":"Zhang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0228","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2019.09.013","article-title":"Food allergy in restaurants work group report","volume":"8","author":"Carter","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2023.09.015_bib0229","unstructured":"Food Allergy Research & Education. Public access to epinephrine. Available at: https:\/\/www.foodallergy.org\/public-access-epinephrine. Accessed September 15, 2022."},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0230","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jaip.2018.07.029","article-title":"To stock or not to stock? implementation of epinephrine autoinjectors in food establishments","volume":"7","author":"Waserman","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0231","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0091-6749(99)70133-8","article-title":"Self-reported allergic reactions to peanut on commercial airliners","volume":"104","author":"Sicherer","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0232","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1081-1206(10)60835-6","article-title":"Allergic reactions to peanuts, tree nuts, and seeds aboard commercial airliners","volume":"101","author":"Comstock","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0233","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaip.2013.01.002","article-title":"International study of risk-mitigating factors and in-flight allergic reactions to peanut and tree nut","volume":"1","author":"Greenhawt","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0234","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaci.2009.06.039","article-title":"Self-reported allergic reactions to peanut and tree nuts occurring on commercial airlines","volume":"124","author":"Greenhawt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-7022-2-12","article-title":"The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad","volume":"2","author":"Barnett","year":"2012","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0236","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaip.2018.10.043","article-title":"Management of peanut allergy","volume":"7","author":"Venter","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0237","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s40629-020-00147-1","article-title":"Airlines provide too little information for allergy sufferers!","volume":"29","author":"Seidenberg","year":"2020","journal-title":"Allergo J Int"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0238","doi-asserted-by":"crossref","first-page":"e13414","DOI":"10.2196\/13414","article-title":"Proximity-based emergency response communities for patients with allergies who are at risk of anaphylaxis: clustering analysis and scenario-based survey sudy","volume":"7","author":"Gaziel Yablowitz","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0239","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1365-2222.2009.03324.x","article-title":"The natural history and epidemiology of insect venom allergy: clinical implications","volume":"39","author":"Bilo","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0240","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ACI.0000000000000565","article-title":"Impact of climate change on insect-human interactions","volume":"19","author":"Vega","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0241","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0242","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaip.2018.08.025","article-title":"The use of medical alert jewelry to communicate allergy information","volume":"7","author":"Le","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0243","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/anae.13958","article-title":"Medical identification or alert jewellery: an opportunity to save lives or an unreliable hindrance?","volume":"72","author":"Rahman","year":"2017","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0244","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000945","article-title":"Cardiopulmonary resuscitation and public access defibrillation in the current era\u2013can we do better yet?","volume":"3","author":"Berger","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0245","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000533","article-title":"Outcomes of out-of-hospital cardiac arrest by public location in the public-access defibrillation era","volume":"3","author":"Murakami","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0246","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5811\/westjem.2015.3.25337","article-title":"Epinephrine for anaphylaxis: underutilized and unavailable","volume":"16","author":"Dudley","year":"2015","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.anai.2023.09.015_bib0247","unstructured":"Food Allergy & Anaphylaxis Connection Team. Government Relations: stock epinephrine entity laws. Available at: https:\/\/www.foodallergyawareness.org\/government-relations\/stock-epinephrine-entity-laws\/. Accessed September 14, 2022."},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0249","doi-asserted-by":"crossref","first-page":"e13892","DOI":"10.2196\/13892","article-title":"Childrens\u2019 and parents\u2019 willingness to join a smartphone-based emergency response community for anaphylaxis: survey","volume":"7","author":"Khalemsky","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.anai.2020.06.021","article-title":"Epinephrine autoinjectors on airplanes","volume":"125","author":"O'Connor","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0251","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.jaip.2019.04.029","article-title":"Cost-effectiveness of stock epinephrine autoinjectors on commercial aircraft","volume":"7","author":"Shaker","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0252","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/ACI.0000000000000680","article-title":"Epinephrine in anaphylaxis: too little, too late","volume":"20","author":"Lieberman","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0253","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4006","article-title":"Epinephrine for first-aid management of anaphylaxis","volume":"139","author":"Sicherer","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0254","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pai.12458","article-title":"The compliance and burden of treatment with the epinephrine auto-injector in food-allergic adolescents","volume":"27","author":"Saleh-Langenberg","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anai.2019.12.021","article-title":"Quality of life in food allergic children: results from 174 quality-of-life patient questionnaires","volume":"124","author":"Miller","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.anai.2023.09.015_bib0256","first-page":"19","article-title":"Oral immunotherapy for food allergies","volume":"68","author":"Feuille","year":"2016","journal-title":"Ann Nutr Metab"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0257","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11882-015-0546-9","article-title":"Food protein-induced enterocolitis syndrome, allergic proctocolitis, and enteropathy","volume":"15","author":"Feuille","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"10187","key":"10.1016\/j.anai.2023.09.015_bib0258","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0259","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000507445","article-title":"Drug-induced anaphylaxis: an update on epidemiology and risk factors","volume":"181","author":"Regateiro","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0260","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2017.00614","article-title":"Epidemiology, mechanisms, and diagnosis of drug-induced anaphylaxis","volume":"8","author":"Monta\u00f1ez","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0261","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2222.2009.03214.x","article-title":"Safety and tolerability of omalizumab","volume":"39","author":"Corren","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0262","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jaci.2007.09.032","article-title":"American Academy of Allergy, Asthma & Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis","volume":"120","author":"Cox","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0263","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2011.04.010","article-title":"American Academy of Allergy, Asthma & Immunology\/American College of Allergy, Asthma & Immunology omalizumab-Associated Anaphylaxis Joint Task Force follow-up report","volume":"128","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0264","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jaci.2017.07.013","article-title":"Anaphylaxis associated with omalizumab administration: risk factors and patient characteristics","volume":"140","author":"Lieberman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.rmed.2017.07.013","article-title":"Long-term \u201creal-life\u201d safety of omalizumab in patients with severe uncontrolled asthma: a nine-year study","volume":"130","author":"Di Bona","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2023.09.015_bib0266","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2018.06.021","article-title":"Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: a long-term post-marketing study in Japan","volume":"141","author":"Adachi","year":"2018","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0267","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2019.09.037","article-title":"Estimation of health and economic benefits of clinic versus home administration of omalizumab and mepolizumab","volume":"8","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0268","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaci.2022.01.009","article-title":"Managing risk of anaphylaxis in patients receiving allergen immunotherapy: assessing benefit versus risk","volume":"149","author":"Bernstein","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0269","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ACI.0000000000000335","article-title":"Allergen immunotherapy: an updated review of safety","volume":"17","author":"James","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.iac.2019.09.001","article-title":"Subcutaneous immunotherapy safety: incidence per surveys and risk factors","volume":"40","author":"S\u00e1nchez-Borges","year":"2020","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0271","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.anai.2014.02.008","article-title":"Systemic reactions to inhalant immunotherapy using 1:1 target dosing","volume":"112","author":"Holland","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0272","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2217\/imt-2020-0123","article-title":"Sublingual immunotherapy for food allergy and its future directions","volume":"12","author":"Schworer","year":"2020","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0273","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.anai.2019.09.009","article-title":"The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy","volume":"123","author":"Sun","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0274","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13223-021-00634-2","article-title":"CSACI position statement: transition recommendations on existing epinephrine autoinjectors","volume":"17","author":"Li","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-017-0225-6","article-title":"CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens","volume":"14","author":"Quirt","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0276","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2021.03.042","article-title":"Use of multiple epinephrine doses in anaphylaxis: a systematic review and meta-analysis","volume":"148","author":"Patel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0277","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jaip.2021.01.007","article-title":"A cost-effectiveness analysis of epinephrine autoinjector risk stratification for patients with food allergy: one epinephrine autoinjector or two?","volume":"9","author":"Shaker","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0278","first-page":"751","article-title":"Use of multiple doses of adrenaline for food-induced anaphylaxis","volume":"67","author":"Araki","year":"2018","journal-title":"Arerugi"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0279","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s40521-018-0168-2","article-title":"Risk factors and cofactors for severe anaphylaxis","volume":"5","author":"De Feo","year":"2018","journal-title":"Curr Treat Options Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0281","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0282","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaip.2021.10.008","article-title":"Fatal food anaphylaxis: distinguishing fact from fiction","volume":"10","author":"Anagnostou","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0283","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.anai.2017.07.014","article-title":"Risk factors for severe anaphylaxis in the United States","volume":"119","author":"Motosue","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0284","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/cea.13516","article-title":"Identifying and managing patients at risk of severe allergic reactions to food: report from two iFAAM workshops","volume":"49","author":"Roberts","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0285","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.5415\/apallergy.2021.11.e8","article-title":"Predictors of serious outcomes among patients with anaphylaxis seen in the Philippine national tertiary hospital","volume":"11","author":"Tan-Lim","year":"2021","journal-title":"Asia Pac Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0286","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2020.07.031","article-title":"Peanut allergy diagnosis: a 2020 practice parameter update, systematic review, and GRADE analysis","volume":"146","author":"Greenhawt","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0287","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1542\/peds.105.2.359","article-title":"Use assessment of self-administered epinephrine among food-allergic children and pediatricians","volume":"105","author":"Sicherer","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0288","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaip.2014.07.004","article-title":"Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization","volume":"3","author":"Fleming","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0289","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.jaci.2016.02.016","article-title":"Increasing visits for anaphylaxis and the benefits of early epinephrine administration: a 4-year study at a pediatric emergency department in Montreal, Canada","volume":"137","author":"Hochstadter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mai.2001.112031","article-title":"Fatalities due to anaphylactic reactions to foods","volume":"107","author":"Bock","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0291","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4005","article-title":"Guidance on Completing a Written Allergy and Anaphylaxis Emergency Plan","volume":"139","author":"Wang","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2023.09.015_bib0292","unstructured":"American Academy of Allergy, Asthma & Immunology. Anaphlyaxis emergency action plan. Available at: https:\/\/www.aaaai.org\/aaaai\/media\/medialibrary\/pdf%20documents\/libraries\/anaphylaxis-emergency-action-plan.pdf. Accessed September 7, 2022."},{"key":"10.1016\/j.anai.2023.09.015_bib0293","unstructured":"Food Allergy Research & Education. Food allergy & anaphylaxis emergency care plan. Available at: https:\/\/www.foodallergy.org\/living-food-allergies\/food-allergy-essentials\/food-allergy-anaphylaxis-emergency-care-plan. Accessed September 15, 2022."},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0294","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.anai.2022.10.024","article-title":"Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: an integrated analysis","volume":"130","author":"Tanimoto","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.anai.2014.04.016","article-title":"What affects quality of life among caregivers of food-allergic children?","volume":"113","author":"Howe","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0296","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","article-title":"Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine","volume":"3","author":"Campbell","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0297","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000477566","article-title":"Safety of adrenaline use in anaphylaxis: a multicentre register","volume":"173","author":"Cardona","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0298","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jaip.2018.04.006","article-title":"Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature","volume":"6","author":"Shaker","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0299","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2023.09.015_bib0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.resuscitation.2016.12.020","article-title":"Epinephrine use in older patients with anaphylaxis: clinical outcomes and cardiovascular complications","volume":"112","author":"Kawano","year":"2017","journal-title":"Resuscitation"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0301","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.jaip.2019.04.040","article-title":"Age-related cardiovascular outcomes in older adults receiving epinephrine for anaphylaxis in the emergency department","volume":"7","author":"O'Brien","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0302","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaip.2018.10.042","article-title":"Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies","volume":"7","author":"Tejedor-Alonso","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0303","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/all.14785","article-title":"\u03b2-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy","volume":"76","author":"Sturm","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.09.015_bib0304","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2016.11.266","article-title":"Takotsubo cardiomyopathy associated with epinephrine use: a systematic review and meta-analysis","volume":"229","author":"Nazir","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.anai.2023.09.015_bib0305","doi-asserted-by":"crossref","first-page":"A352","DOI":"10.1016\/j.chest.2019.08.394","article-title":"Epinephrine-induced ST-elevation myocardial infarction (STEMI) in the setting of anaphylaxis","volume":"156","author":"Saeed","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.anai.2023.09.015_bib0306","article-title":"Intramuscular epinephrine-induced transient ST-elevation myocardial infarction","volume":"6","author":"Shrestha","year":"2018","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0307","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ACI.0000000000000855","article-title":"Anaphylaxis in elderly people","volume":"22","author":"Ventura","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0308","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.annemergmed.2015.07.011","article-title":"Lacerations and embedded needles caused by epinephrine autoinjector use in children","volume":"67","author":"Brown","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.anai.2023.09.015_bib0309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-020-00418-0","article-title":"Hooked epinephrine auto-injector devices in children: four case reports with three different proposed mechanisms","volume":"16","author":"Goldman","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0310","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/MJT.0000000000000541","article-title":"Unintentional epinephrine auto-injector injuries: a National Poison Center observational study","volume":"26","author":"Anshien","year":"2019","journal-title":"Am J Ther"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0311","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.surge.2020.01.005","article-title":"Adrenaline auto-injector injuries to digits: a systematic review and recommendations for emergency management","volume":"18","author":"Walsh","year":"2020","journal-title":"Surgeon"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0312","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.anai.2018.09.189","article-title":"Attitudes and beliefs toward epinephrine auto-injector price increase","volume":"121","author":"Wang","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0313","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/JAA.S159851","article-title":"Economic considerations in the treatment of systemic allergic reactions","volume":"11","author":"Westermann-Clark","year":"2018","journal-title":"J Asthma Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0314","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.anai.2017.05.020","article-title":"Economic evaluation of epinephrine auto-injectors for peanut allergy","volume":"119","author":"Shaker","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0315","first-page":"665","article-title":"The high cost of epinephrine autoinjectors and possible alternatives","volume":"5","author":"Pepper","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0316","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.iac.2021.09.004","article-title":"Anaphylaxis: access to epinephrine in outpatient setting","volume":"42","author":"Westermann-Clark","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0317","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.09.038","article-title":"The effect of provision of an adrenaline autoinjector on quality of life in children with food allergy","volume":"131","author":"Pinczower","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0318","doi-asserted-by":"crossref","first-page":"e13663","DOI":"10.1111\/pai.13663","article-title":"Health-related quality of life of food-allergic children compared with healthy controls and other diseases","volume":"33","author":"Frachette","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0319","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.alit.2021.01.006","article-title":"Association between allergic diseases and mental health among Japanese adolescents","volume":"70","author":"Imai","year":"2021","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0320","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1067\/mai.2002.125827","article-title":"Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom","volume":"110","author":"Oude Elberink","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0321","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/jpepsy\/jsv058","article-title":"Pediatric food allergies and psychosocial functioning: examining the potential moderating roles of maternal distress and overprotection","volume":"40","author":"Chow","year":"2015","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.anai.2023.09.015_bib0329","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-020-00422-4","article-title":"Epinephrine auto-injector needle length: the impact of winter clothing","volume":"16","author":"Dreborg","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0492","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.anai.2018.09.456","article-title":"Authors\u2019 response","volume":"121","author":"Dreborg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0322","unstructured":"PR Newswire. U.S. FDA approves Kal\u00e9o's AUVI-Q\u00ae (Epinephrine injection, USP) 0.1-mg auto-injector for life-threatening allergic reactions in infants and small children. Available at: https:\/\/www.prnewswire.com\/news-releases\/us-fda-approves-kaleos-auvi-q-epinephrine-injection-usp-01-mg-auto-injector-for-life-threatening-allergic-reactions-in-infants-and-small-children-300559170.html. Accessed September 15, 2022."},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0323","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.anai.2018.05.001","article-title":"Epinephrine, auto-injectors, and anaphylaxis: challenges of dose, depth, and device","volume":"121","author":"Brown","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0324","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1542\/peds.2006-3689","article-title":"Self-injectable epinephrine for first-aid management of anaphylaxis","volume":"119","author":"Sicherer","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0325","first-page":"AB6","article-title":"What dose of epinephrine? Safety and pharmacokinetics of 0.5mg versus 0.3mg epinephrine by autoinjector in food-allergic teenagers: a randomized cross-over trial","volume":"145","author":"Patel","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0326","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/ACI.0000000000000283","article-title":"Epinephrine auto-injector needle length: what is the ideal length?","volume":"16","author":"Song","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0327","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13601-020-00326-x","article-title":"Epinephrine delivery via EpiPen(\u00ae) Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances","volume":"10","author":"Worm","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0328","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.anai.2019.04.027","article-title":"Implications of variation of epinephrine auto-injector needle length","volume":"123","author":"Dreborg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0330","doi-asserted-by":"crossref","first-page":"82","DOI":"10.21911\/aai.526","article-title":"What should the optimal adrenaline auto-injector needle length be?","volume":"18","author":"Turk","year":"2020","journal-title":"Asthma Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0331","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1081-1206(10)61130-1","article-title":"Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues","volume":"94","author":"Song","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0332","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1710-1492-10-39","article-title":"Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy","volume":"10","author":"Tsai","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0333","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaip.2017.09.021","article-title":"Bioavailability and cardiovascular effects of adrenaline administered by Anapen autoinjector in healthy volunteers","volume":"6","author":"Duvauchelle","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0334","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cea.14055","article-title":"Pharmacokinetics of adrenaline autoinjectors","volume":"52","author":"Turner","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0335","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1016\/j.jaip.2021.05.028","article-title":"Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: a survey of practitioners","volume":"9","author":"Ponda","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2023.09.015_bib0336","unstructured":"Weir A, Arg\u00e1ez C. Epinephrine auto-injectors for anaphylaxis: a review of the clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563019\/. Accessed September 15, 2022."},{"key":"10.1016\/j.anai.2023.09.015_bib0337","doi-asserted-by":"crossref","unstructured":"Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE, et al. Patients\u2019 ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial. Allergy. 2015;70(7):855-863.","DOI":"10.1111\/all.12628"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0338","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.anai.2019.06.005","article-title":"Usability and preference of epinephrine auto-injectors: Auvi-Q and EpiPen JR","volume":"123","author":"Kessler","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0339","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2013.02.004","article-title":"Auvi-Q versus EpiPen: preferences of adults, caregivers, and children","volume":"1","author":"Camargo","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/allergies3020008","article-title":"Is switching of adrenaline auto injector devices a concern for anaphylaxis management? A cross-sectional study","volume":"3","author":"Cronin","year":"2023","journal-title":"Allergies"},{"key":"10.1016\/j.anai.2023.09.015_bib0341","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/JAA.S159400","article-title":"Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities","volume":"11","author":"Prince","year":"2018","journal-title":"J Asthma Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0342","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15586\/aei.v50i5.582","article-title":"Benefit of educational intervention on autoinjector technique for caregivers and paediatric patients with food allergies: a literature review","volume":"50","author":"Trujillo","year":"2022","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0343","first-page":"14","article-title":"Effect of instruction on the ability to use a self-administered epinephrine injector","volume":"14","author":"Segal","year":"2012","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0344","doi-asserted-by":"crossref","first-page":"AB153","DOI":"10.1016\/j.jaci.2018.12.464","article-title":"Outcomes of simulated use of Epinephrine injection USP auto-injectors","volume":"143","author":"Peterson","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0345","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000504365","article-title":"Is there an optimal training interval to improve the correct use of adrenaline auto-injectors?","volume":"181","author":"Sirin Kose","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0346","doi-asserted-by":"crossref","first-page":"AB232","DOI":"10.1016\/j.jaci.2019.12.111","article-title":"Epinephrine auto-injector parental survey and skills demonstration","volume":"145","author":"Southall","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0347","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anai.2020.12.011","article-title":"Self vs partnered epinephrine autoinjector training, performance differences in an anaphylaxis simulation","volume":"126","author":"Kaminski","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0348","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaip.2018.09.025","article-title":"Extended analysis of parent and child confidence in recognizing anaphylaxis and using the epinephrine autoinjector during oral food challenges","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0349","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.anai.2020.07.028","article-title":"One-year sustained impact of supervised epinephrine autoinjector administration during food challenge on parent confidence","volume":"125","author":"Soller","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0350","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaip.2016.12.016","article-title":"Food-allergic adolescents at risk for anaphylaxis: a randomized controlled study of supervised injection to improve comfort with epinephrine self-Injection","volume":"5","author":"Shemesh","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2023.09.015_bib0351","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13601-018-0230-y","article-title":"A qualitative study exploring parents\u2019 experiences with epinephrine use for their child's anaphylactic reaction","volume":"8","author":"Chooniedass","year":"2018","journal-title":"Clin Transl Allergy"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0352","doi-asserted-by":"crossref","first-page":"918","DOI":"10.7326\/L16-0612","article-title":"Epinephrine concentrations in EpiPens after the expiration date","volume":"166","author":"Cantrell","year":"2017","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0353","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jaip.2019.04.028","article-title":"Epinephrine drug degradation in autoinjector products","volume":"7","author":"Kassel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0354","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.jaip.2022.05.024","article-title":"Enantiomeric degradation of epinephrine in autoinjector products","volume":"10","author":"Kassel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0355","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.anai.2019.08.332","article-title":"P353 epinephrine autoinjector education: a quality improvement project","volume":"123","author":"Patrawala","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0356","doi-asserted-by":"crossref","first-page":"AB3","DOI":"10.1016\/j.jaci.2019.12.835","article-title":"Adoption of 2016 EpiPen administration instructions by pediatric emergency department staff","volume":"145","author":"Samstein","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0357","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/iid3.264","article-title":"Improving adrenaline autoinjector adherence: a psychologically informed training for healthcare professionals","volume":"7","author":"Mahoney","year":"2019","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.anai.2023.09.015_bib0358","first-page":"639","article-title":"Anaphylaxis and adrenaline autoinjector training, where do the responsibilities lie: results from a UK general practice survey","volume":"76","author":"Dua","year":"2021","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0359","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2021-001742","article-title":"Improving epinephrine autoinjector usability and carriage frequency among patients at risk of anaphylaxis: a quality improvement initiative","volume":"11","author":"Ziyar","year":"2022","journal-title":"BMJ Open Qual"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0360","doi-asserted-by":"crossref","first-page":"AB152","DOI":"10.1016\/j.jaci.2018.12.460","article-title":"Efficacy of video-based training to improve epinephrine autoinjector use competency","volume":"143","author":"Chow","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0361","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2020.10.e32","article-title":"Utility of an educational video on epinephrine prefilled syringe usage for anaphylaxis: a randomized control trial","volume":"10","author":"Yuenyongviwat","year":"2020","journal-title":"Asia Pac Allergy"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0362","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005648","article-title":"Pharmacists\u2019 response to anaphylaxis in the community (PRAC): a randomised, simulated patient study of pharmacist practice","volume":"4","author":"Salter","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0363","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.12.347","article-title":"Improving knowledge of epinephrine auto-injector use and peanut guidelines at an academic medical center","volume":"145","author":"Aguilera","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0364","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jpc.13696","article-title":"Improving anaphylaxis management by health care professional education and practical skills training in a regional centre","volume":"53","author":"Kaur","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.anai.2023.09.015_bib0365","first-page":"1663","article-title":"The development and evaluation of Anaphylaxis Toolkit, a competency based online education course for Allied Healthcare Professionals (AHP's): a pilot study","volume":"51","author":"Wright","year":"2021","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0366","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0367","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaip.2017.12.020","article-title":"Patients taking beta-blockers do not require increased doses of epinephrine for anaphylaxis","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0368","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaci.2005.06.019","article-title":"Beta-blockers and anaphylaxis: are the risks overstated?","volume":"116","author":"Miller","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"10.1016\/j.anai.2023.09.015_bib0369","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0370","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jaip.2019.10.020","article-title":"Risk for anaphylactic reaction from cardiac catheterization in patients receiving beta-adrenergic blockers or angiotensin-converting enzyme-inhibitors","volume":"8","author":"Smith","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0371","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaip.2017.05.009","article-title":"Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions","volume":"5","author":"Carlson","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0372","first-page":"48","article-title":"Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication","volume":"53","author":"Awai","year":"1984","journal-title":"Ann Allergy"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0373","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jama.1984.03340350026019","article-title":"Beta-blockade in stinging insect anaphylaxis","volume":"251","author":"Ingall","year":"1984","journal-title":"JAMA"},{"issue":"8824","key":"10.1016\/j.anai.2023.09.015_bib0374","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0140-6736(92)93314-D","article-title":"ACE inhibitors and anaphylactoid reactions during venom immunotherapy","volume":"340","author":"Tunon-de-Lara","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0375","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","article-title":"Use of beta-blockers during immunotherapy for Hymenoptera venom allergy","volume":"115","author":"M\u00fcller","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0376","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Ru\u00ebff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0377","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0378","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Ru\u00ebff","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0379","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Ru\u00ebff","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0380","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2015.03.001","article-title":"Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective","volume":"114","author":"Stoevesandt","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0381","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0382","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2020.06.008","article-title":"Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry","volume":"147","author":"Francuzik","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0383","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.jaip.2021.04.045","article-title":"Biomarkers of the severity of honeybee sting reactions and the severity and threshold of systemic adverse events during immunotherapy","volume":"9","author":"Kopac","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0384","first-page":"977","article-title":"Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis","volume":"113","author":"TenBrook","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0385","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/ACI.0000000000000657","article-title":"Beta-blockers and angiotensin-converting enzyme inhibitors with sublingual immunotherapy: are risks related to individual product safety profile?","volume":"20","author":"Smith","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0386","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.anai.2016.12.009","article-title":"Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update","volume":"118","author":"Greenhawt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0387","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.iac.2021.09.012","article-title":"Systemic allergic reactions and anaphylaxis associated with allergen immunotherapy","volume":"42","author":"Dhamija","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0388","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.anai.2017.02.012","article-title":"Physicians\u2019 experience and opinion on contraindications to allergen immunotherapy: the CONSIT survey","volume":"118","author":"Rodriguez Del Rio","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0389","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5415\/apallergy.2012.2.4.280","article-title":"Biphasic anaphylaxis to gemifloxacin","volume":"2","author":"Yilmaz","year":"2012","journal-title":"Asia Pac Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0390","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.mej.0000217993.09364.35","article-title":"Paradoxical reaction to epinephrine induced by beta-blockers in an anaphylactic shock induced by penicillin","volume":"13","author":"Goddet","year":"2006","journal-title":"Eur J Emerg Med"},{"issue":"17","key":"10.1016\/j.anai.2023.09.015_bib0391","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.1993.00410170119012","article-title":"Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders","volume":"153","author":"Lang","year":"1993","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0392","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3889\/oamjms.2018.513","article-title":"Adverse reactions to intravenous immunoglobulins - our experience","volume":"6","author":"Kareva","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0393","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1536\/ihj.19-568","article-title":"Clinical characteristics, treatment, and outcomes in patients with idiopathic inflammatory myopathy concomitant with heart failure","volume":"61","author":"Liu","year":"2020","journal-title":"Int Heart J"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0394","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/cei.13665","article-title":"Intravenous immunoglobulin and the current risk of moderate and severe anaphylactic events, a cohort study","volume":"206","author":"Martinez","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0395","series-title":"Intravenous immunoglobulin (IVIG)","author":"Arumugham","year":"2022"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0396","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2500\/aap.2021.42.210081","article-title":"Idiopathic anaphylaxis: diagnosis and management","volume":"42","author":"Burrows","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0397","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/all.15318","article-title":"Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis","volume":"77","author":"Turner","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0398","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00130832-200308000-00012","article-title":"A current review of idiopathic anaphylaxis","volume":"3","author":"Lenchner","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0399","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","article-title":"Cardiovascular disease and anaphylaxis","volume":"7","author":"M\u00fcller","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"19","key":"10.1016\/j.anai.2023.09.015_bib0400","first-page":"1885","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0001","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaip.2017.02.008","article-title":"Risk factor analysis of anaphylactic reactions in patients with systemic mastocytosis","volume":"5","author":"G\u00fclen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0401","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2021.02.023","article-title":"Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis","volume":"148","author":"Gulen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0402","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.iac.2016.08.017","article-title":"Mastocytosis and anaphylaxis","volume":"37","author":"Schuch","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0403","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","article-title":"Mastocytosis and insect venom allergy","volume":"10","author":"Bonadonna","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0404","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaci.2018.10.063","article-title":"Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: a Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology","volume":"143","author":"Carter","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0405","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0406","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0407","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0408","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/17474086.2014.955008","article-title":"The serum tryptase test: an emerging robust biomarker in clinical hematology","volume":"7","author":"Valent","year":"2014","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0409","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0410","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/ijms22052684","article-title":"Mediator-related symptoms and anaphylaxis in children with mastocytosis","volume":"22","author":"Brockow","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0411","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the classification and treatment of mastocytosis: current status and outlook toward the future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0412","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0413","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11882-017-0748-4","article-title":"Mastocytosis in children","volume":"17","author":"Klaiber","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0414","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.iac.2018.04.009","article-title":"Pediatric expression of mast cell activation disorders","volume":"38","author":"Broesby-Olsen","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0415","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"Selb","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0416","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0417","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","article-title":"A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients","volume":"38","author":"Doyle","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0418","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1398-9995.2009.02108.x","article-title":"How much specific is the association between Hymenoptera venom allergy and mastocytosis?","volume":"64","author":"Bonadonna","year":"2009","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0419","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18176\/jiaci.0233","article-title":"Prevalence of clonal mast cell disorders in patients presenting with Hymenoptera venom anaphylaxis might be higher than expected","volume":"28","author":"Vazquez-Revuelta","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0421","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.015_bib0422","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0423","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jaci.2021.04.013","article-title":"Prevalence of mastocytosis and Hymenoptera venom allergy in the United States","volume":"148","author":"Schuler","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0424","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Oude Elberink JNG. Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0425","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1046\/j.1365-2133.1999.03214.x","article-title":"Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels","volume":"141","author":"Biedermann","year":"1999","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.anai.2023.09.015_bib0426","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","article-title":"Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy","volume":"33","author":"Haeberli","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"9253","key":"10.1016\/j.anai.2023.09.015_bib0427","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0428","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.iac.2014.02.004","article-title":"Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients","volume":"34","author":"Niedoszytko","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0429","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2007.11.010","article-title":"Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis","volume":"121","author":"Gonzalez de Olano","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0430","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaip.2013.06.014","article-title":"Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations","volume":"1","author":"Bonadonna","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0431","first-page":"225","article-title":"Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab","volume":"19","author":"Galera","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0432","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2007.01604.x","article-title":"High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis","volume":"63","author":"Kontou-Fili","year":"2008","journal-title":"Allergy"},{"issue":"1 Pt 1","key":"10.1016\/j.anai.2023.09.015_bib0433","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)81058-5","article-title":"Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis","volume":"99","author":"Oude Elberink","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0434","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.jaip.2021.03.011","article-title":"Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis","volume":"9","author":"Vitte","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0435","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.iac.2014.01.009","article-title":"Molecular defects in mastocytosis: KIT and beyond KIT","volume":"34","author":"Bibi","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0436","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0437","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.jaip.2021.06.011","article-title":"Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review","volume":"9","author":"G\u00fclen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0438","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ACI.0000000000000781","article-title":"Update on omalizumab in allergen immunotherapy","volume":"21","author":"Dantzer","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0439","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaci.2020.11.005","article-title":"A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis","volume":"147","author":"Carter","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0440","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.anai.2021.06.017","article-title":"Use of omalizumab for management of idiopathic anaphylaxis: a systematic review and retrospective case series","volume":"127","author":"Kaminsky","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0441","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/all.13237","article-title":"Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: efficacy and safety observations","volume":"73","author":"Broesby-Olsen","year":"2018","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0442","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000504842","article-title":"Efficacy of omalizumab in mastocytosis: allusive indication obtained from a prospective, double-blind, multicenter study (XOLMA study)","volume":"236","author":"Distler","year":"2020","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0443","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jaip.2019.03.039","article-title":"Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS","volume":"7","author":"Lemal","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0444","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2007.03.032","article-title":"Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis","volume":"119","author":"Carter","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0445","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaip.2018.07.041","article-title":"Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis","volume":"7","author":"Constantine","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0446","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/cea.13592","article-title":"Omalizumab in the treatment of adult patients with mastocytosis: a systematic review","volume":"50","author":"Jendoubi","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.anai.2023.09.015_bib0447","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood-2014-12-614743","article-title":"Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis","volume":"126","author":"Barete","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0448","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jaci.2022.04.020","article-title":"Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: are we there yet?","volume":"149","author":"Akin","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"10.1016\/j.anai.2023.09.015_bib0449","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0450","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41591-021-01538-9","article-title":"Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 Explorer trial","volume":"27","author":"DeAngelo","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0451","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41591-021-01539-8","article-title":"Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 Pathfinder trial","volume":"27","author":"Gotlib","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0452","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jaci.2020.03.044","article-title":"Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis","volume":"146","author":"Hartmann","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0453","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaci.2018.06.003","article-title":"Midostaurin in patients with indolent systemic mastocytosis: an open-label phase 2 trial","volume":"142","author":"van Anrooij","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0454","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.jaip.2021.02.040","article-title":"Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: prompt resolution of anaphylaxis with the addition of avapritinib","volume":"9","author":"Kudlaty","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0455","doi-asserted-by":"crossref","first-page":"AB336","DOI":"10.1016\/j.jaci.2019.12.062","article-title":"Pioneer: a randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent or smoldering systemic mastocytosis (SM) with symptoms inadequately controlled by standard therapy","volume":"145","author":"Akin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0456","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.anai.2020.10.001","article-title":"Incidence of and risk factors for perioperative or periprocedural anaphylaxis in the United States from 2005 to 2014","volume":"126","author":"Gonzalez-Estrada","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0457","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bja\/aet117","article-title":"Survival from perioperative anaphylaxis in Western Australia 2000-2009","volume":"111","author":"Gibbs","year":"2013","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0458","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bja.2018.04.015","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.anai.2023.09.015_bib0459","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/all.12426","article-title":"Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis","volume":"69","author":"Reitter","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2014.11.005","article-title":"Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States","volume":"3","author":"Gonzalez-Estrada","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0461","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/ALN.0000000000000276","article-title":"Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia","volume":"121","author":"Laroche","year":"2014","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0462","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000542-200309000-00007","article-title":"Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000","volume":"99","author":"Mertes","year":"2003","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0463","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France: an 8-year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0464","first-page":"189","article-title":"[Tryptase levels are elevated during spontaneous ischemic episodes in unstable angina but not after the ergonovine test in variant angina]","volume":"43","author":"Cuculo","year":"1998","journal-title":"Cardiologia"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0465","doi-asserted-by":"crossref","first-page":"AB87","DOI":"10.1016\/j.jaci.2017.12.281","article-title":"Tryptase as a biomarker of mast cell activation in perioperative anaphylaxis: survey from a Belgium reference centre","volume":"141","author":"Faber","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0466","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/bja\/80.1.26","article-title":"Mast cell tryptase in anaesthetic anaphylactoid reactions","volume":"80","author":"Fisher","year":"1998","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0467","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/bja\/aei198","article-title":"Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing?","volume":"95","author":"Kroigaard","year":"2005","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0468","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18176\/jiaci.0236","article-title":"Practical guidelines for perioperative hypersensitivity reactions","volume":"28","author":"Laguna","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0469","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaip.2022.08.049","article-title":"The nonirritating concentrations of neuromuscular blocking agents and related compounds","volume":"11","author":"Gonzalez-Estrada","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2023.09.015_bib0470","unstructured":"Ledford DL. Anaphylaxis evaluation and prevention of recurrent reactions. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/perioperative-anaphylaxis-evaluation-and-prevention-of-recurrent-reactions. Accessed August 15, 2023."},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0471","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jaip.2016.05.011","article-title":"Cefazolin hypersensitivity: toward optimized diagnosis","volume":"4","author":"Uyttebroek","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.09.015_bib0472","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0473","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-6576.2010.02326.x","article-title":"Follow-up after anaesthetic anaphylaxis","volume":"55","author":"Fisher","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0474","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2014.11.011","article-title":"Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia","volume":"3","author":"Guyer","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0475","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bja.2018.02.033","article-title":"Outcome of repeat anaesthesia after investigation for perioperative anaphylaxis","volume":"120","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0476","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1034\/j.1398-9995.2001.056005461.x","article-title":"False negative SPT after anaphylaxis","volume":"56","author":"Aalto-Korte","year":"2001","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2023.09.015_bib0477","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1398-9995.2005.00963.x","article-title":"EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy","volume":"60","author":"Bil\u00f3","year":"2005","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0478","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0091-6749(97)70222-7","article-title":"Timing of venom skin tests and IgE determinations after insect sting anaphylaxis","volume":"100","author":"Goldberg","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0479","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jclinpath-2019-206157","article-title":"Empty mast cell syndrome: fallacy or fact?","volume":"73","author":"Mohamed","year":"2020","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.015_bib0480","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/all.12154","article-title":"Early skin testing is effective for diagnosis of hypersensitivity reactions occurring during anesthesia","volume":"68","author":"Lafuente","year":"2013","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0481","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.09.015_bib0482","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/112_2020_53","article-title":"Ligands and signaling of mas-related G protein-coupled receptor-X2 in mast cell activation","volume":"179","author":"Mi","year":"2021","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.015_bib0483","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2022.09.004","article-title":"MRGPRX2 in drug allergy: what we know and what we do not know","volume":"151","author":"Kolkhir","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.015_bib0484","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.bja.2019.03.018","article-title":"The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.anai.2023.09.015_bib0485","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2021.8515","article-title":"Risk of second allergic reaction to SARS-CoV-2 vaccines: a systematic review and meta-analysis","volume":"182","author":"Chu","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"6 Pt 2","key":"10.1016\/j.anai.2023.09.015_bib0486","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1081-1206(10)62886-4","article-title":"Role and application of provocation in the diagnosis of occupational latex allergy","volume":"83","author":"Kurtz","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.09.015_bib0487","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-5908-4-75","article-title":"Dual equipoise shared decision making: definitions for decision and behaviour support interventions","volume":"4","author":"Elwyn","year":"2009","journal-title":"Implement Sci"},{"issue":"12","key":"10.1016\/j.anai.2023.09.015_bib0488","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.1985.00360120065011","article-title":"Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of beta-adrenergic antagonists","volume":"145","author":"Greenberger","year":"1985","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.anai.2023.09.015_bib0489","first-page":"409","article-title":"Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts","volume":"73","author":"Portnoy","year":"1994","journal-title":"Ann Allergy"},{"issue":"7652","key":"10.1016\/j.anai.2023.09.015_bib0490","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7454","key":"10.1016\/j.anai.2023.09.015_bib0491","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623013042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623013042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:33:25Z","timestamp":1761053605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623013042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":489,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1081120623013042"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.09.015","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis: A 2023 practice parameter update","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}